We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Captopril vs Rosuvastatin (Crestor): Rosuvastatin (Crestor) has the stronger overall evidence (4.5 vs 3.5/10); they're alternatives for support heart health — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Rosuvastatin (Crestor) wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (1)
Outcomes where both Captopril and Rosuvastatin (Crestor) have evidence — compare verdict strength side-by-side.
Off-label longevity use mirrors low antihypertensive dosing (captopril is short-acting; longer-acting ACE inhibitors like lisinopril/ramipril are often used) under a clinician. Not an approved longevity regimen; blood pressure and potassium should be monitored.
any
Oral tablet (or a longer-acting ACE inhibitor)
5–20 mg once daily (up to 40 mg in selected high-risk patients), titrated to LDL/ApoB targets — under a clinician. A prescription drug; not a self-directed supplement regimen.
any
Oral tablet (rosuvastatin 5–20 mg)
Unknown in humans
Months to years
Years
Throughout use
2–4 weeks
Months to years
1–2 years
Throughout use
Angiotensin Converting Enzyme (ACE) Inhibitor Extends Caenorhabditis elegans Life Span.
PLoS genetics (2016) · Animal
ACE inhibition extended lifespan in the worm C. elegans
The ACE inhibitor captopril inhibits ACN-1 to control dauer formation and aging.
Development (Cambridge, England) (2024) · Animal
Captopril specifically inhibits the worm ACE homolog ACN-1
Control of aging by the renin-angiotensin system: a review of C. elegans, Drosophila, and mammals.
Frontiers in pharmacology (2022) · Review
Review framing RAS/ACE modulation as a conserved aging pathway
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
The New England journal of medicine (2008) · Rct · n=17802
JUPITER randomized placebo-controlled primary-prevention trial (~17,800 participants with normal LDL but elevated hsCRP)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
Lancet (London, England) (2010) · Meta analysis
Meta-analysis of ~170,000 participants across 26 randomized statin trials
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
JAMA (2006) · Open label · n=507
ASTEROID open-label IVUS trial (507 enrolled; 349 with evaluable serial imaging)
Rosuvastatin (Crestor) has a higher evidence score (4.5/10 vs 3.5/10) and wins in 3 of 3 categories.
For support heart health, Rosuvastatin (Crestor) has a higher relevance score (78 vs 62).
No known interactions between Captopril and Rosuvastatin (Crestor) have been documented in our database. However, always consult a healthcare provider before combining supplements.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.